Find a Tender
complete
Official procurement procedure
NHS National Framework for Golimumab Injection
No classification published
Location not published
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS England: "NHS National Framework for Golimumab Injection". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
| Contracting Authority | NHS England | Scope & Categories | Not published | Submission Window | complete No deadline published |
|---|---|---|---|---|---|
| Submission Gateway | Direct notice route | Legal Basis & Regime | Standard procurement | Estimated Value (exc. VAT) | Not published |
Bidder Intelligence · Authority Profile: NHS England
Market Analytics
Derived from OCDS awards & bid statistics
Published history for NHS England. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Average Price Reduction
Not availableInsufficient comparable data
Competition Density
22.8Bids / Report
Supplier ConcentrationModerate Concentration
Anna FreudTop vendor: 29.6% of attributable valuePayment Terms
Check noticePublished terms
Coverage: 859 active published awards; 13 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Price reduction compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Historical Awarded Suppliers With This Authority:
| Supplier Name | Historic Awards | Attributable GBP Value |
|---|---|---|
| Anna Freud | 1 win | £5,862,540 |
| Anglia Ruskin University | 1 win | £4,809,159 |
| NHS Shared Business Services Limited | 1 win | £4,393,727 |
| Pearson Professional Assessments Limited | 1 win | £4,374,320 |
| Timewise Foundation CIC | 1 win | £166,667 |
Procedure terms
Contracting AuthorityNHS England | Procedure methodNot published | Procurement categoryNot published |
Statuscomplete | Framework / DPSFramework | CompetitionNot published |
Above thresholdNot published | Legal basisNot published | Tender period startsNot published |
Clarification deadlineNot published | Electronic submissionNot published | Submission languagesNot published |
Published17 Oct 2025, 17:40 BST | Last source update17 Oct 2025, 17:40 BST | Recurring procurementNot published |
ClassificationNot published | ||
Delivery areaLocation not published | ||
OCIDocds-h6vhtk-052c77 | ||
What is being bought
NHS National Framework for Golimumab Injection commencing 1st November 2025
Offer reference number: CM/TNS/25/5724
Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
What changed
From the official release history
- Official notice release published
17 Oct 2025, 17:40 BST - tender value changed
1 Sept 2025, 10:26 BST - Status changed to complete
1 Sept 2025, 10:26 BST - Official notice release published
1 Sept 2025, 10:26 BST - Submission deadline changed to published date
1 Sept 2025, 10:26 BST - Published value updated to £107,912,000
14 Jul 2025, 15:39 BST - Status changed to active
14 Jul 2025, 15:39 BST - Official notice release published
14 Jul 2025, 15:39 BST - Submission deadline changed to 12 Aug 2025, 13:00 BST
14 Jul 2025, 15:39 BST - Published value updated to £90,000,000
4 Jun 2025, 14:23 BST - Status changed to planning
4 Jun 2025, 14:23 BST - Official notice release published
4 Jun 2025, 14:23 BST - Buyer information updated
4 Jun 2025, 14:23 BST
Lots and requirements (1)
Published by the contracting authority
- Lot 1 · #1Individual lot title not publishedcompletePublished valueNot publishedThe source published no individual title or description for this lot.Contract periodNot publishedEligibilityNot publishedOptions / renewalNot published
Timeline
- Procedure published
17 Oct 2025, 17:40 BST - Award active
Not published · Not published - Contract active
Signed 23 Sept 2025, 00:00 BST · £60,000,000
Commercial outcome and competition
Awards Janssen Cilag Ltd, Mercury Pharmaceuticals Lt, Orifarm UK Not published · Not published · active |
Contracts NHS National Framework for Golimumab Injection commencing 1st November 2025 £60,000,000 · signed 23 Sept 2025, 00:00 BST · active Contract period: 1 Nov 2025, 00:00 GMT — 31 Oct 2026, 23:59 GMT |
Bid statisticsNo aggregate bid statistics published |
Buyer and organisations in this procedure
NHS England
Contracting authority GB-PPON-PDPT-3135-BWWYDocuments (1)
Official links; attachments are not copied
Related procedures (0)
No related procedures published